ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Advisors and Bankers
Live Quote
 
 

Auditors :
Adler Shine, Aston House, Cornwall Avenue, FInchley, N3 1LF

Nominated Advisors :
WH Ireland, 11 St James's Square, Manchester M2 6WH, www.wh-ireland.co.uk

Joint Nominated Brokers :
Old Park Lane Capital plc, 55 Park Lane, London, W1K 1NA, www.oldplc.com
WH Ireland, 11 St James's Square, Manchester M2 6WH. www.wh-ireland.co.uk

Corporate Advisors :
Korral Partners Limited, 70 Conduit Street, London, W1S 2GF. www.korral.com

Registrars :
Capita Registrars, The Registry, 34 Beckenham Road, Beckenham, BR3 4TU

Bankers :
The Royal Bank of Scotland, Argylle House, 246 Regent Street, London, W1B 3PB

Solicitors :
Bircham Dyson Bell, 50 Broadway, London, SW1H 0BL, UK

Public Relations :
College Hill, contact Sue Charles or Justine Lamond, Tel: +44 (0)20 7457 2020,
email: valirx@collegehill.com